CL2014002506A1 - Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido. - Google Patents

Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido.

Info

Publication number
CL2014002506A1
CL2014002506A1 CL2014002506A CL2014002506A CL2014002506A1 CL 2014002506 A1 CL2014002506 A1 CL 2014002506A1 CL 2014002506 A CL2014002506 A CL 2014002506A CL 2014002506 A CL2014002506 A CL 2014002506A CL 2014002506 A1 CL2014002506 A1 CL 2014002506A1
Authority
CL
Chile
Prior art keywords
composition
tablet
produce
disacarids
oligosaccharides
Prior art date
Application number
CL2014002506A
Other languages
English (en)
Spanish (es)
Inventor
Moti Harel
Brian Carpenter
Qiong Tang
Trisha Rice
Kimberly Jennings
Roger Drewes
Elizabeth Raditsis
Original Assignee
Advanced Bionutrition Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Bionutrition Corp filed Critical Advanced Bionutrition Corp
Publication of CL2014002506A1 publication Critical patent/CL2014002506A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P30/00Shaping or working of foodstuffs characterised by the process or apparatus
    • A23P30/30Puffing or expanding
    • A23P30/32Puffing or expanding by pressure release, e.g. explosion puffing; by vacuum treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2014002506A 2012-03-23 2014-09-23 Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido. CL2014002506A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261614994P 2012-03-23 2012-03-23
US201261642094P 2012-05-03 2012-05-03
US201261646337P 2012-05-13 2012-05-13

Publications (1)

Publication Number Publication Date
CL2014002506A1 true CL2014002506A1 (es) 2015-01-09

Family

ID=49223367

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014002506A CL2014002506A1 (es) 2012-03-23 2014-09-23 Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido.

Country Status (18)

Country Link
EP (1) EP2827905B1 (enExample)
JP (1) JP6229188B2 (enExample)
KR (1) KR102062645B1 (enExample)
CN (2) CN104244985A (enExample)
AR (1) AR093204A1 (enExample)
AU (1) AU2013234931B2 (enExample)
BR (1) BR112014023234B1 (enExample)
CA (1) CA2866889C (enExample)
CL (1) CL2014002506A1 (enExample)
ES (1) ES3016483T3 (enExample)
IN (1) IN2014DN08599A (enExample)
MX (1) MX356072B (enExample)
MY (1) MY178686A (enExample)
NZ (1) NZ628912A (enExample)
PH (1) PH12014502092B1 (enExample)
RU (1) RU2666601C2 (enExample)
SG (1) SG11201405478VA (enExample)
WO (1) WO2013142792A1 (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140255583A1 (en) * 2013-03-06 2014-09-11 Sunny Delight Beverages Company Protein suspension as a beverage opacifier system
MY195765A (en) 2013-10-25 2023-02-10 Nch Corp Delivery System and Probiotic Composition for Animals and Plants
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
JP6731416B2 (ja) * 2015-02-11 2020-07-29 プレヴテック マイクロビア インコーポレイテッド 生きている大腸菌を埋め込むための改良された乾燥マトリクス、その製造方法及びその使用
KR102685914B1 (ko) * 2015-07-29 2024-07-16 어드밴스드 바이오뉴트리션 코프. 특수 식이 용도를 위한 안정한 프로바이오틱 건조 조성물
MX395197B (es) * 2015-12-04 2025-03-19 Advanced Bionutrition Corp Composiciones secas estables que no tienen o contienen pocos azucares.
WO2017103742A1 (en) * 2015-12-18 2017-06-22 Nestec Sa Hydration for animals
FR3045384B1 (fr) * 2015-12-18 2020-02-07 Institut National De La Recherche Agronomique Composition lyophilisee pour la conservation de microbiote dans son ecosysteme
CN105504050A (zh) * 2016-03-03 2016-04-20 河南欧普生物科技有限公司 一种抗安卡拉病毒鸡卵黄抗体的制备方法
US10897922B2 (en) 2016-04-05 2021-01-26 Nch Corporation Composition and method for germinative compounds in probiotic food and beverage products for human consumption
US12097226B2 (en) 2016-04-05 2024-09-24 Nch Corporation System and method for using a single-serve nutrient spore composition for small scale farm applications
CN108884434B (zh) 2016-04-05 2023-06-09 Nch公司 富含营养的萌发剂组合物及孢子培养方法
RU2749883C2 (ru) * 2016-06-14 2021-06-18 Эланко Кэнэда Лимитед Гранулированный корм для животных, содержащий кормовую добавку, способ его получения и применения
PL3476226T3 (pl) 2016-06-24 2024-08-19 Yessinergy Holding S/A Kompozycja immunomodulująca i promująca wzrost oraz kontrolująca niepożądane bakterie mikrobioty jelitowej i jej zastosowanie
KR101766430B1 (ko) 2016-10-28 2017-08-08 주식회사 삼양사 올리고당을 함유하는 알룰로오스 시럽 및 그 제조방법
CN106819418A (zh) * 2017-03-27 2017-06-13 张军军 一种超高脂饲料及其制备方法
US10323226B2 (en) * 2017-03-30 2019-06-18 Nch Corporation Feed material for biomass generator
GB201708932D0 (en) * 2017-06-05 2017-07-19 Probi Ab Microbial compositions
WO2020007906A1 (en) * 2018-07-04 2020-01-09 Chr. Hansen A/S Aqueous topical compositions comprising viable probiotic bacteria
WO2020007931A1 (en) 2018-07-04 2020-01-09 Chr. Hansen A/S Topical compositions comprising viable probiotic bacteria
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
CA3117725A1 (en) * 2018-10-26 2020-04-30 Danisco Us Inc Stable microbial composition and drying process
EP3891112A4 (en) * 2018-12-07 2022-11-09 Pivot Bio, Inc. STABILITY-ENHANCED POLYMERIC COMPOSITIONS FOR NITROGEN-FIXING MICROBIAL PRODUCTS
WO2020130770A1 (es) * 2018-12-19 2020-06-25 Ajtzakbio S.A.P.I. De C.V. Composición probiótica de alto valor sin necesidad de cadena de frio, desarrollada para reducir el impacto ambiental, aumentar la producción y mejorar la supervivencia de larvas de camarón
US20220389369A1 (en) * 2019-09-16 2022-12-08 Vedanta Biosciences, Inc. Methods and compositions for preserving bacteria
MX2022004950A (es) * 2019-10-22 2022-05-16 Massachusetts Inst Technology Composiciones a base de biomateriales para entregar microbios que promueven el crecimiento de las plantas.
CN110923145B (zh) * 2019-12-16 2021-07-20 天康制药(苏州)有限公司 支原体的冻干保护剂与冻干支原体及其制备方法
WO2021159068A1 (en) 2020-02-06 2021-08-12 Nch Corportion Composition and method of using germinative compounds in probiotics for inflammation reduction in humans
US20230080017A1 (en) * 2020-02-19 2023-03-16 Zantebio Limited Coated microcapsules and methods for the production thereof
RU2736064C1 (ru) * 2020-04-03 2020-11-11 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Защитная среда для стабилизации клеток возбудителя туляремии в процессе приготовления и хранения сухих препаратов
RU2746022C1 (ru) * 2020-04-03 2021-04-06 Федеральное государственное бюджетное учреждение "48 Центральный научно-исследовательский институт" Министерства обороны Российской Федерации Способ стабилизации бактериальных клеток чумного микроба перед сублимационным высушиванием
CA3172321A1 (en) 2020-05-01 2021-11-04 Farzaneh REZAEI Stable liquid formulations for nitrogen-fixing microorganisms
JP2022102198A (ja) * 2020-12-25 2022-07-07 ライオン株式会社 内服固形剤
US20240041951A1 (en) * 2020-12-25 2024-02-08 Hayashibara Co., Ltd. Method for improving productivity in livestock and/or poultry and method for improving intestinal flora in livestock and/or poultry
JP2024508212A (ja) * 2021-02-10 2024-02-26 ディーエスエム アイピー アセッツ ビー.ブイ. 粉末状組成物(i)
JP2024506466A (ja) * 2021-02-10 2024-02-14 ディーエスエム アイピー アセッツ ビー.ブイ. 粉末状組成物(ii)
CN112843328B (zh) * 2021-02-25 2022-05-13 山东大学 一种具有抑菌作用的鲍鱼壳粉/ZnO复合材料掺杂的智能水凝胶伤口敷料的制备方法
CN113621519B (zh) * 2021-08-11 2023-07-18 河南农业大学 一种复合酵母冻干保护剂
CN119255821A (zh) * 2021-08-25 2025-01-03 奥古斯汀·T·兹维纳瓦什 微生物组递送平台
WO2023050121A1 (zh) * 2021-09-29 2023-04-06 中国科学院过程工程研究所 一种基于氨基酸的玻璃
CN114196579A (zh) * 2021-12-13 2022-03-18 张峰 一种建筑通风工程用的甲醛微生物净化器
EP4512388A1 (en) * 2022-04-21 2025-02-26 Obshchestvo S Ogranichennoj Otvetstvennostyu «Kinetik-Farm» Means for intravaginal delivery of an active ingredient and method for producing and using same
CN116040604B (zh) * 2022-12-21 2025-04-29 天津华电南疆热电有限公司 一种用于微生物培养的碳源材料及其制备方法
CN116694581A (zh) * 2023-05-24 2023-09-05 华南农业大学 哈维氏弧菌噬菌体v-ydf132的冻干保护剂及其保藏方法
CN117256857B (zh) * 2023-07-24 2025-12-02 浙江大学 一种用于制备鱼油微胶囊的复合壁材及其制备方法与应用
WO2025055959A1 (en) * 2023-09-12 2025-03-20 Bing Biotech Limited Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith
CN117247305A (zh) * 2023-09-16 2023-12-19 鲁东大学 一种促进植物根系生长的水凝胶及制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212045B1 (en) * 1999-08-24 2016-08-17 Abic Biological Laboratories Ltd. A vaccine composition and method of using the same
ES2162746B1 (es) * 1999-10-21 2003-02-16 Lipotec Sa Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
CZ301813B6 (cs) 2000-06-27 2010-06-30 F. Hoffmann-La Roche Ag Zpusob prípravy farmaceutické kompozice
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
WO2003087327A2 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Preservation of bioactive materials by freeze dried foam
US20060105938A1 (en) * 2002-09-16 2006-05-18 Andries Siemensma Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
US8871266B2 (en) * 2003-10-01 2014-10-28 Commonwealth Scientific & Industrial Research Organisation Probiotic storage and delivery
EP1616486A1 (en) * 2004-07-13 2006-01-18 Friesland Brands B.V. Powdered compositions containing an edible oil and their use in food products
JP5214464B2 (ja) * 2005-12-28 2013-06-19 アドバンスド バイオニュートリション コーポレーション 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
WO2008076975A1 (en) * 2006-12-18 2008-06-26 Advanced Bionutrition Corporation A dry food product containing live probiotic
BRPI0820584A2 (pt) * 2007-12-20 2015-07-14 Abbott Lab Pó nutricional estável
AU2009306497B2 (en) * 2008-10-20 2015-01-29 Société des Produits Nestlé S.A. Nutritional composition with anti-regurgitation properties
TWI468157B (zh) * 2009-04-29 2015-01-11 Intervet Int Bv 形成錠劑的方法,進行該方法的系統及包含該錠劑的包裝物
US20110070334A1 (en) * 2009-09-20 2011-03-24 Nagendra Rangavajla Probiotic Stabilization
ES2676656T3 (es) * 2010-08-13 2018-07-23 Advanced Bionutrition Corp. Composición estabilizante de almacenamiento en seco para materiales biológicos

Also Published As

Publication number Publication date
AR093204A1 (es) 2015-05-27
KR102062645B1 (ko) 2020-01-06
AU2013234931A1 (en) 2014-09-18
EP2827905B1 (en) 2025-03-12
CA2866889A1 (en) 2013-09-26
MY178686A (en) 2020-10-20
EP2827905C0 (en) 2025-03-12
AU2013234931A2 (en) 2014-12-04
BR112014023234A2 (pt) 2017-06-20
MX2014011122A (es) 2014-12-05
JP6229188B2 (ja) 2017-11-15
EP2827905A1 (en) 2015-01-28
WO2013142792A1 (en) 2013-09-26
CA2866889C (en) 2021-08-31
EP2827905A4 (en) 2015-05-06
NZ628912A (en) 2016-06-24
ES3016483T3 (en) 2025-05-09
RU2014136089A (ru) 2016-05-20
BR112014023234A8 (pt) 2018-01-16
RU2666601C2 (ru) 2018-09-11
CN114601849A (zh) 2022-06-10
KR20140135845A (ko) 2014-11-26
CN104244985A (zh) 2014-12-24
JP2015517985A (ja) 2015-06-25
BR112014023234B1 (pt) 2020-12-08
PH12014502092B1 (en) 2019-11-20
SG11201405478VA (en) 2014-11-27
AU2013234931B2 (en) 2017-12-07
MX356072B (es) 2018-05-14
PH12014502092A1 (en) 2014-11-24
IN2014DN08599A (enExample) 2015-05-22

Similar Documents

Publication Publication Date Title
CL2014002506A1 (es) Composición estabilizante para materiales bioactivos que comprende un componente carbohidrato que comprende oligosacaridos, disacaridos y polisacaridos, y proteinas hidrolizadas; metodo para producir la composicion; un liquido, un polvo, un comprimido, una pella, una capsula, un alimento que comprende la composicion; metodo para producir el comprimido.
IL246941B (en) A pharmaceutical preparation containing erythrocyte thermalizing plp-dependent enzyme and its cofactor
SG11201510671SA (en) A method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions
CL2015000823A1 (es) Sistema de preparacion de alimentos configurado para producir un producto alimenticio, que comprende una maquina de preparacion de alimentos, y una capsula alimenticia que encierra una cavidad, donde dicha maquina comprende un medio de inyeccion unico y un medio de sellado; metodo; capsula.
BR112015021298A2 (pt) cápsula de dose individual e processo para a preparação de uma bebida com uma cápsula de dose individual
CL2014002717A1 (es) Formulación compuesta que comprende una tableta esferoidal de multiunidades (musti) encapsulada en cápsula dura y método para preparar la misma.
ZA201508454B (en) Method of applying a composition and pharmaceutical composition with a regimen of administering it, including photo-activating the active component
IL243226A0 (en) History of pyrazole, their preparation and pharmaceutical preparations containing them
EP3058833A4 (en) Complex carbohydrate formulation for fodder, fodder comprising same, and application
HUE060018T2 (hu) Ízletességet fokozó anyagok állateledelhez, eljárás elõállításukra és alkalmazásuk
EP3219318A4 (en) Multi-layered tablet containing drug unstable with respect to light
PL3318278T3 (pl) Kompozycja farmaceutyczna obejmująca kolagen i hialuronian sodu
MX2017008127A (es) Producto alimenticio envuelto y procedimiento para la produccion de un producto alimenticio empacado.
EP3018061A4 (en) Seal head, and container sealed using said seal head
PT3024755T (pt) Cápsula para produtos de infusão
IT1402461B1 (it) Metodo e macchina per il riempimento di capsule o simili con almeno due prodotti, in particolare prodotti farmaceutici in granuli
IL246406A0 (en) History of imidazopyrazinone, their preparation and pharmaceutical preparations containing them
IL243227A0 (en) History of diaminocyclopentane carboxamide, their preparation and pharmaceutical preparations containing them
IL242438B (en) Dosage form soft pharmaceutical gelatin capsule
IL243223A0 (en) History of imidazole, their preparation and pharmaceutical preparations containing them
IL239874B (en) History of acylguanidine, their preparation and pharmaceutical preparations containing them
IL246297A0 (en) History of pyrazine, their preparation and pharmaceutical preparations containing them
ES1126055Y (es) Envase para medicamentos, productos dietéticos y productos similares.
HUP1600414A2 (hu) Bisoprololt és ramiprilt tartalmazó stabil kombinációs gyógyszerkészítmény
EP3065737A4 (en) Oral pharmaceutical form for preventing vascular diseases, tablet as pharmaceutical form and gelatin capsule as pharmaceutical form